Case Study “Pharmaceutical Companies, Intellectual Property, and the Global AIDS Epidemic,”

Case Study “Pharmaceutical Companies, Intellectual Property, and the Global AIDS Epidemic,”

What are the principal arguments of pharmaceutical companies that oppose making exceptions to IPR laws for developing countries? What are the arguments by NGOs and others for relaxing IPR laws?